Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish.

Matsui H, Ito H, Taniguchi Y, Takeda S, Takahashi R.

J Neurochem. 2010 Dec;115(5):1150-60. doi: 10.1111/j.1471-4159.2010.07012.x. Epub 2010 Oct 26.

2.

A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish.

Matsui H, Taniguchi Y, Inoue H, Uemura K, Takeda S, Takahashi R.

Neurosci Res. 2009 Nov;65(3):263-71. doi: 10.1016/j.neures.2009.07.010. Epub 2009 Aug 7.

PMID:
19665499
3.

Exploring the pathogenetic mechanisms underlying Parkinson's disease in medaka fish.

Matsui H, Uemura N, Yamakado H, Takeda S, Takahashi R.

J Parkinsons Dis. 2014;4(2):301-10. doi: 10.3233/JPD-130289. Review.

PMID:
24366926
4.

Proteasome inhibition in medaka brain induces the features of Parkinson's disease.

Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahashi R.

J Neurochem. 2010 Oct;115(1):178-87. doi: 10.1111/j.1471-4159.2010.06918.x. Epub 2010 Aug 12.

5.

Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats.

Inden M, Kondo J, Kitamura Y, Takata K, Nishimura K, Taniguchi T, Sawada H, Shimohama S.

J Pharmacol Sci. 2005 Feb;97(2):203-11. Epub 2005 Jan 30.

6.

Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

Sherer TB, Kim JH, Betarbet R, Greenamyre JT.

Exp Neurol. 2003 Jan;179(1):9-16.

PMID:
12504863
7.

Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.

Porritt MJ, Batchelor PE, Howells DW.

Exp Neurol. 2005 Mar;192(1):226-34.

PMID:
15698637
8.

Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.

Xie W, Li X, Li C, Zhu W, Jankovic J, Le W.

J Neurochem. 2010 Oct;115(1):188-99. doi: 10.1111/j.1471-4159.2010.06914.x. Epub 2010 Aug 19.

9.

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.

Zhang X, Xie W, Qu S, Pan T, Wang X, Le W.

Biochem Biophys Res Commun. 2005 Jul 29;333(2):544-9.

PMID:
15950935
10.

Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.

McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA.

Neurobiol Dis. 2002 Jul;10(2):119-27.

PMID:
12127150
11.

Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.

Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S.

J Neurosci Res. 2009 Feb;87(2):576-85. doi: 10.1002/jnr.21869.

PMID:
18803299
13.

KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.

Väänänen AJ, Rauhala P, Tuominen RK, Liesi P.

J Neurosci Res. 2006 Aug 15;84(3):655-65.

PMID:
16810683
14.

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S.

J Neurochem. 2000 Feb;74(2):721-9.

15.

NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease.

Crocker SJ, Wigle N, Liston P, Thompson CS, Lee CJ, Xu D, Roy S, Nicholson DW, Park DS, MacKenzie A, Korneluk RG, Robertson GS.

Eur J Neurosci. 2001 Jul;14(2):391-400.

PMID:
11553289
16.

Animal models in neurodegenerative diseases.

Hirsch EC.

J Neural Transm Suppl. 2007;(72):87-90. Review.

PMID:
17982881
17.

Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.

Cicchetti F, Lapointe N, Roberge-Tremblay A, Saint-Pierre M, Jimenez L, Ficke BW, Gross RE.

Neurobiol Dis. 2005 Nov;20(2):360-71.

PMID:
16242641
18.

RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.

Bando Y, Katayama T, Taniguchi M, Ishibashi T, Matsuo N, Ogawa S, Tohyama M.

Neurobiol Dis. 2005 Feb;18(1):143-51.

PMID:
15649705
19.

Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.

Pierre SR, Lemmens MA, Figueiredo-Pereira ME.

J Neuroinflammation. 2009 Jul 25;6:18. doi: 10.1186/1742-2094-6-18.

20.

Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology.

Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, Eisenhauer PB, Fine RE, Wells JM.

Brain Res. 2004 Oct 1;1022(1-2):164-72.

PMID:
15353226

Supplemental Content

Support Center